Determinants of Vaccination Choices Among Individuals with Inflammatory Rheumatic and Musculoskeletal Disorders: A Qualitative Study - Scorecard - MDSpire

Determinants of Vaccination Choices Among Individuals with Inflammatory Rheumatic and Musculoskeletal Disorders: A Qualitative Study

  • By

  • Anastasia Suslow

  • Romy Lauer

  • Uta Kiltz

  • Chantal Giehl

  • Kerstin Hellwig

  • Theresa Oganowski

  • Thomas Grüter

  • Maria Zacharopoulou

  • Andreas Stallmach

  • Anika Franz

  • Ursula Marschall

  • Joachim Saam

  • Catharina Schumacher

  • Stephanie Stock

  • Dusan Simic

  • Arim Shukri

  • Kathrin Schlößler

  • Ina Carola Otte

  • Horst Christian Vollmar

  • January 7, 2026

  • 0 min

Share

Clinical Scorecard: Determinants of Vaccination Choices Among Individuals with Inflammatory Rheumatic and Musculoskeletal Disorders: A Qualitative Study

At a Glance

CategoryDetail
ConditionInflammatory rheumatic and musculoskeletal diseases (iRMD)
Key MechanismsHigh inflammatory burden and immunosuppressive medication increase infection risk
Target PopulationPatients with iRMD, particularly older adults
Care SettingOutpatient care primarily via general practitioners and specialists in Germany

Key Highlights

  • Patients with iRMD have elevated risk for infections such as influenza and pneumococcal disease.
  • Vaccination coverage among iRMD patients in Germany is inadequate, with only about 25% adherence to guidelines.
  • Vaccinations are reimbursed by statutory and private health insurance, with flexible access to specialists.

Guideline-Based Recommendations

Diagnosis

  • Regularly check vaccination status in patients with iRMD to ensure complete coverage.

Management

  • Provide vaccination counselling coordinated between general practitioners and specialists.
  • Implement recommended vaccinations according to Standing Committee on Vaccination (STIKO) guidelines with chronic condition considerations.

Monitoring & Follow-up

  • Monitor vaccination uptake and adherence in iRMD patients to identify gaps.

Risks

  • Increased susceptibility to infections due to disease activity and immunosuppressive therapy.

Patient & Prescribing Data

Individuals with inflammatory rheumatic and musculoskeletal diseases in Germany

Despite reimbursement and recommendations, vaccination uptake remains low, indicating barriers in patient and physician behavior.

Clinical Best Practices

  • Use qualitative insights from patients and physicians to identify barriers and facilitators to vaccination.
  • Enhance interprofessional coordination between GPs and rheumatologists for vaccination counselling and documentation.
  • Employ systematic frameworks (COM-B, TDF, CFIR) to understand and improve vaccination decision-making processes.

References

Original Source(s)

Related Content